Purpose of this document

The purpose of this national policy document is to:-

• define the arrangements for the quality assessment of licensed medicines in support of the national contracting process.
• define the roles and responsibilities of Regional Quality Assurance (QA) specialists in the contracting process for licensed medicines
• ensure equity and consistency of the quality and medication error potential assessment process and ongoing contract support
• to define the process for reporting the outcome of the quality and medication error potential assessments to contracting teams and purchasers to support risk based decision making.

Attachments

• QA Policy August 2017 · Word